Shailender Bhatia, MD
@bhatia-s-md.bsky.social
Medical oncologist passionate about immunotherapy, focusing on skin cancers, esp. Melanoma and Merkel cell carcinoma. Opinions represent my own views.
Reposted by Shailender Bhatia, MD
Congrats to @isbscience.org's Dr. Mary Brunkow on this tremendous honor! Fred Hutch is proud to be neighbors with ISB in Seattle’s South Lake Union neighborhood —a global hub of life sciences innovation. It’s inspiring to see such transformative research happening just down the street!
This morning, @isbscience.org's Dr. Mary Brunkow was awarded the 2025 Nobel Prize in Physiology or Medicine! Dr. Brunkow shares the award with Fred Ramsdell and Shimon Sakaguchi. Read the press release here: www.nobelprize.org/.../medicine....
What a tremendous honor! Congratulations!
What a tremendous honor! Congratulations!
October 6, 2025 at 5:09 PM
Congrats to @isbscience.org's Dr. Mary Brunkow on this tremendous honor! Fred Hutch is proud to be neighbors with ISB in Seattle’s South Lake Union neighborhood —a global hub of life sciences innovation. It’s inspiring to see such transformative research happening just down the street!
Reposted by Shailender Bhatia, MD
New Journal for ImmunoTherapy of Cancer article: Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response jitc.bmj.com/content/13/9...
#JITC #ImmunoSky
#JITC #ImmunoSky
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response
Background The presence of tertiary lymphoid structures (TLS) in solid tumors, including Merkel cell carcinoma (MCC), is associated with a better prognosis and a better response to immunotherapy with ...
jitc.bmj.com
October 1, 2025 at 1:35 PM
New Journal for ImmunoTherapy of Cancer article: Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response jitc.bmj.com/content/13/9...
#JITC #ImmunoSky
#JITC #ImmunoSky
Reposted by Shailender Bhatia, MD
📢🔬 Join Our Team! #MC3Institute is hiring 2 paid, full-time Clinical Research Fellows! Help improve #MerkelcellCarcinoma care thru patient support, clinical trials, & research, under the mentorship of Dr. Paul Nghiem. @fredhutch.org
Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship
Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship
October 1, 2025 at 8:00 PM
📢🔬 Join Our Team! #MC3Institute is hiring 2 paid, full-time Clinical Research Fellows! Help improve #MerkelcellCarcinoma care thru patient support, clinical trials, & research, under the mentorship of Dr. Paul Nghiem. @fredhutch.org
Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship
Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship
Reposted by Shailender Bhatia, MD
Happy Independence Day, Nigeria!🎉We proudly highlight our recent partnership with the Federal Medical Center, Ebute Metta, Lagos, aimed at enhancing cancer care infrastructure and outcomes. See here for the power of global collaboration in service of health equity: buff.ly/uTD0ZuA#Glob...
Binaytara Signs MOU with Federal Medical Center Ebute Metta to Advance Cancer Care
Binaytara has signed a memorandum of understanding with the Federal Medical Center Ebute Metta in Lagos, Nigeria, to strengthen cancer care through infrastructure, training, and system support as…
binaytara.org
October 1, 2025 at 10:31 PM
Happy Independence Day, Nigeria!🎉We proudly highlight our recent partnership with the Federal Medical Center, Ebute Metta, Lagos, aimed at enhancing cancer care infrastructure and outcomes. See here for the power of global collaboration in service of health equity: buff.ly/uTD0ZuA#Glob...
Reposted by Shailender Bhatia, MD
I’ve seen firsthand how a single breakthrough can change a patient’s life. The Cancer AI Alliance is designed to bring more of those breakthroughs to more patients and make even a greater difference.
Congrats to Jeff Leek, Brian Bot and all the CAIA collaborators on this remarkable accomplishment!
Congrats to Jeff Leek, Brian Bot and all the CAIA collaborators on this remarkable accomplishment!
The Cancer AI Alliance (CAIA) today unveiled its first collaborative #AI platform for #cancerresearch. The secure, scalable, multi-cloud platform uses federated learning, maintaining data security and privacy while learning from millions of clinical data points. https://bit.ly/4nvm3NF
Cancer AI Alliance unveils first collaborative AI platform for cancer research - Cancer AI Alliance
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments
bit.ly
October 1, 2025 at 10:08 PM
I’ve seen firsthand how a single breakthrough can change a patient’s life. The Cancer AI Alliance is designed to bring more of those breakthroughs to more patients and make even a greater difference.
Congrats to Jeff Leek, Brian Bot and all the CAIA collaborators on this remarkable accomplishment!
Congrats to Jeff Leek, Brian Bot and all the CAIA collaborators on this remarkable accomplishment!
Reposted by Shailender Bhatia, MD
In a study of #MCC patients, researchers found stopping immune checkpoint inhibitor therapy is associated w/ a higher risk of disease progression — 39% at 2 years compared w/ 14% among those who continued treatment.
Learn More 👉 tinyurl.com/ydnr2fck
@uwdermatology.bsky.social @fredhutch.bsky.social
Learn More 👉 tinyurl.com/ydnr2fck
@uwdermatology.bsky.social @fredhutch.bsky.social
September 4, 2025 at 8:54 PM
In a study of #MCC patients, researchers found stopping immune checkpoint inhibitor therapy is associated w/ a higher risk of disease progression — 39% at 2 years compared w/ 14% among those who continued treatment.
Learn More 👉 tinyurl.com/ydnr2fck
@uwdermatology.bsky.social @fredhutch.bsky.social
Learn More 👉 tinyurl.com/ydnr2fck
@uwdermatology.bsky.social @fredhutch.bsky.social
Reposted by Shailender Bhatia, MD
Read more: blog-ecog-acrin.org/ecog-acrin-n...
ECOG-ACRIN Names University of Washington’s and Fred Hutch Cancer Center’s Petros Grivas as its Young Investigator of the Year
Dr. Grivas is honored as an international key opinion thought leader who has made outstanding contributions to genitourinary cancer research, clinical practice, leadership, teaching and mentorship, an...
blog-ecog-acrin.org
July 2, 2025 at 6:44 PM
Read more: blog-ecog-acrin.org/ecog-acrin-n...
Reposted by Shailender Bhatia, MD
Congratulations to Dr. Petros Grivas on receiving the 2025 Young Investigator Award from @eaonc.bsky.social! He's recognized for a distinguished record of innovative research, outstanding clinical practice, and unwavering dedication to advancing the field of genitourinary oncology.
July 2, 2025 at 6:44 PM
Congratulations to Dr. Petros Grivas on receiving the 2025 Young Investigator Award from @eaonc.bsky.social! He's recognized for a distinguished record of innovative research, outstanding clinical practice, and unwavering dedication to advancing the field of genitourinary oncology.
Reposted by Shailender Bhatia, MD
Congratulations to Dr. Vivian Liu, heme-onc fellow in the @stanleyleelab.bsky.social & Stirewalt labs
@fredhutch.bsky.social for receiving this year's ASCO Conquer Cancer Award
@conquercancer.bsky.social! Nice write up by the Fred Hutch news team:
www.fredhutch.org/content/www/...
@fredhutch.bsky.social for receiving this year's ASCO Conquer Cancer Award
@conquercancer.bsky.social! Nice write up by the Fred Hutch news team:
www.fredhutch.org/content/www/...
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of Clinica...
www.fredhutch.org
June 5, 2025 at 3:02 AM
Congratulations to Dr. Vivian Liu, heme-onc fellow in the @stanleyleelab.bsky.social & Stirewalt labs
@fredhutch.bsky.social for receiving this year's ASCO Conquer Cancer Award
@conquercancer.bsky.social! Nice write up by the Fred Hutch news team:
www.fredhutch.org/content/www/...
@fredhutch.bsky.social for receiving this year's ASCO Conquer Cancer Award
@conquercancer.bsky.social! Nice write up by the Fred Hutch news team:
www.fredhutch.org/content/www/...
Reposted by Shailender Bhatia, MD
Dr. Natalie Miller presents results final results from the proof-of-concept investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory #MCC. #ASCO25 meetings.asco.org/abstracts-pr...
June 1, 2025 at 4:35 PM
Dr. Natalie Miller presents results final results from the proof-of-concept investigator-initiated study of combination therapy with anti–PD-1, anti–LAG-3, and anti–TIM-3 in participants with advanced or metastatic PD-(L)1 refractory #MCC. #ASCO25 meetings.asco.org/abstracts-pr...
Reposted by Shailender Bhatia, MD
“Remember that all through history, there have been tyrants and murderers, and for a time, they seem invincible. But in the end, they always fall. Always.”
—Mahatma Gandhi
—Mahatma Gandhi
May 24, 2025 at 5:32 PM
“Remember that all through history, there have been tyrants and murderers, and for a time, they seem invincible. But in the end, they always fall. Always.”
—Mahatma Gandhi
—Mahatma Gandhi
Reposted by Shailender Bhatia, MD
From the Himalayas to health camps in Nepal—my daughter Angira trekked 68 miles to Annapurna Base Camp to raise cancer awareness. Then she rolled up her sleeves, volunteered @binaytara.bsky.social cancer center, Janakpur. Proud of this next-gen global health advocate. binaytara.org/news/health/...
Teen Trekker Highlights Cancer Disparities on Binaytara Nepal Mission
Angira Shah treks to Annapurna Base Camp and volunteers with Binaytara to spotlight cancer screenings, breast cancer care, and disparities in global oncology.
binaytara.org
May 22, 2025 at 2:02 PM
From the Himalayas to health camps in Nepal—my daughter Angira trekked 68 miles to Annapurna Base Camp to raise cancer awareness. Then she rolled up her sleeves, volunteered @binaytara.bsky.social cancer center, Janakpur. Proud of this next-gen global health advocate. binaytara.org/news/health/...
Reposted by Shailender Bhatia, MD
Fred Hutch experts say former President Joe Biden's recent #prostatecancer diagnosis is not a death sentence, thanks in part to Biden's own contributions to advancing cancer research through the #CancerMoonshot. bit.ly/43hFIru
Fred Hutch physicians stress hope after Biden's prostate cancer prognosis
As former President Biden battles "aggressive" prostate cancer, experts remain optimistic due to medical advancements he championed.
bit.ly
May 19, 2025 at 5:28 PM
Fred Hutch experts say former President Joe Biden's recent #prostatecancer diagnosis is not a death sentence, thanks in part to Biden's own contributions to advancing cancer research through the #CancerMoonshot. bit.ly/43hFIru
Reposted by Shailender Bhatia, MD
Did you know melanoma makes up 1% of skin cancers but causes 80% of deaths? Dr. Shailender Bhatia of Fred Hutch & UW stresses prevention. Learn tips on our blog: buff.ly/Jg9hrla ☀️🧴 Follow @bhatia-s-md.bsky.social for more insights! #MelanomaMonday #SkinCancerAwareness
May 6, 2025 at 12:20 AM
Did you know melanoma makes up 1% of skin cancers but causes 80% of deaths? Dr. Shailender Bhatia of Fred Hutch & UW stresses prevention. Learn tips on our blog: buff.ly/Jg9hrla ☀️🧴 Follow @bhatia-s-md.bsky.social for more insights! #MelanomaMonday #SkinCancerAwareness
Reposted by Shailender Bhatia, MD
🌏 The #GlobalOncology session at #SCHD25 featured impactful presentations. Dr. Shailender Bhatia's AFFORD-IO trial in Uganda, with insights from Dr. Vivian Oehler and Dr. Benjamin Li, shows how immunotherapy can become more globally accessible. @fredhutch.bsky.social @uwmedicine.bsky.social
April 26, 2025 at 6:46 PM
🌏 The #GlobalOncology session at #SCHD25 featured impactful presentations. Dr. Shailender Bhatia's AFFORD-IO trial in Uganda, with insights from Dr. Vivian Oehler and Dr. Benjamin Li, shows how immunotherapy can become more globally accessible. @fredhutch.bsky.social @uwmedicine.bsky.social
Reposted by Shailender Bhatia, MD
A study led by Fred Hutch cancer biologist Denise Galloway, PhD, that looked at the staying power of the #HPV vaccine has found that two doses provide the same amount of immune protection as three, with no additional boosters needed. bit.ly/4lHr6do
Fewer doses of cancer-preventing HPV vaccine may be as effective as recommended amount: HealthLink
The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.
bit.ly
April 21, 2025 at 8:54 PM
A study led by Fred Hutch cancer biologist Denise Galloway, PhD, that looked at the staying power of the #HPV vaccine has found that two doses provide the same amount of immune protection as three, with no additional boosters needed. bit.ly/4lHr6do
Reposted by Shailender Bhatia, MD
Honored to celebrate changemakers at #SCHD25! 🎉 Dr. Dan Milner (Humanitarian Award), Dr. Mazyar Shadman (Distinguished Faculty Award), and Judy Delismon (Volunteer of the Year) for their impact in cancer care & equity. Join us Apr 26 in Seattle! @binaytara.bsky.social
🔗 binaytara.org/news/educati...
🔗 binaytara.org/news/educati...
April 14, 2025 at 9:13 PM
Honored to celebrate changemakers at #SCHD25! 🎉 Dr. Dan Milner (Humanitarian Award), Dr. Mazyar Shadman (Distinguished Faculty Award), and Judy Delismon (Volunteer of the Year) for their impact in cancer care & equity. Join us Apr 26 in Seattle! @binaytara.bsky.social
🔗 binaytara.org/news/educati...
🔗 binaytara.org/news/educati...
Reposted by Shailender Bhatia, MD
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We're grateful for their extraordinary commitment. asco.org/about-asco/a...
@adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social
@adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social
March 28, 2025 at 2:04 PM
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We're grateful for their extraordinary commitment. asco.org/about-asco/a...
@adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social
@adesaimd.bsky.social @pgrivasmdphd.bsky.social @sagarlonialmd.bsky.social @pateloncology.bsky.social
Reposted by Shailender Bhatia, MD
We don't know who needs to hear this, but #Spring is coming! The #cherryblossoms are beginning to bloom around Fred Hutch's South Lake Union campus, reminding us that sunnier days are around the corner. 🌸
March 27, 2025 at 9:38 PM
We don't know who needs to hear this, but #Spring is coming! The #cherryblossoms are beginning to bloom around Fred Hutch's South Lake Union campus, reminding us that sunnier days are around the corner. 🌸
Reposted by Shailender Bhatia, MD
March 27, 2025 at 3:25 AM
Reposted by Shailender Bhatia, MD
Less than 1 week until the next #SITC Deep Dive webinar! We will discuss the state & future of TIL therapy, #biology of #TIL therapy, approaches to develop the next generation of TIL #therapies, & considerations when implementing TIL therapy. Register now: sitcancer.org/DeepDive
March 20, 2025 at 8:39 PM
Less than 1 week until the next #SITC Deep Dive webinar! We will discuss the state & future of TIL therapy, #biology of #TIL therapy, approaches to develop the next generation of TIL #therapies, & considerations when implementing TIL therapy. Register now: sitcancer.org/DeepDive
Reposted by Shailender Bhatia, MD
SITC’s new Melanoma CPG Addendum addresses the changing treatment landscape driven by the first approved solid tumor cell therapy, lifileucel, and practice-changing guidance from the NADINA trial. Learn more here: ow.ly/5G0w50VlqHK
#SITCGuidelines #Melanoma #Immunotherapy
@jasonlukemd.bsky.social
#SITCGuidelines #Melanoma #Immunotherapy
@jasonlukemd.bsky.social
March 20, 2025 at 2:13 PM
SITC’s new Melanoma CPG Addendum addresses the changing treatment landscape driven by the first approved solid tumor cell therapy, lifileucel, and practice-changing guidance from the NADINA trial. Learn more here: ow.ly/5G0w50VlqHK
#SITCGuidelines #Melanoma #Immunotherapy
@jasonlukemd.bsky.social
#SITCGuidelines #Melanoma #Immunotherapy
@jasonlukemd.bsky.social
Reposted by Shailender Bhatia, MD
Fred Hutch/@uwmedicine.bsky.social's Dan Lin, Bruce Montgomery and Ruben Raychaudhuri recently published an overview of #prostatecancer (PC) in @jama.com. PC is the most common non-skin cancer in men in the U.S. with ~300K new cases and 35K deaths in 2024. pubmed.ncbi.nlm.nih.gov/40063046/ 1/12
Prostate Cancer: A Review - PubMed
Approximately 1.5 million new cases of prostate cancer are diagnosed annually worldwide. Approximately 75% of patients present with cancer localized to the prostate, which is associated with a 5-year ...
pubmed.ncbi.nlm.nih.gov
March 17, 2025 at 10:24 PM
Fred Hutch/@uwmedicine.bsky.social's Dan Lin, Bruce Montgomery and Ruben Raychaudhuri recently published an overview of #prostatecancer (PC) in @jama.com. PC is the most common non-skin cancer in men in the U.S. with ~300K new cases and 35K deaths in 2024. pubmed.ncbi.nlm.nih.gov/40063046/ 1/12
Reposted by Shailender Bhatia, MD
“Most people who have received two doses of the #MMR vaccine do not need a measles booster shot, but some specific individuals may benefit,” says Deborah Fuller, a @uwmedicine.bsky.social microbiologist. @everydayhealth.bsky.social #vaccine bit.ly/4bHMiv8
March 11, 2025 at 10:49 PM
“Most people who have received two doses of the #MMR vaccine do not need a measles booster shot, but some specific individuals may benefit,” says Deborah Fuller, a @uwmedicine.bsky.social microbiologist. @everydayhealth.bsky.social #vaccine bit.ly/4bHMiv8
Reposted by Shailender Bhatia, MD
Happening now- (CME, ACPE, CNE) live webinar: "Innovations in Immune Checkpoint Inhibitor Delivery" with Dr. Petros Grivas and @bhatia-s-md.bsky.social of @fredhutch.bsky.social education.binayfoundation.org/Vitual-Optim...
March 1, 2025 at 3:25 PM
Happening now- (CME, ACPE, CNE) live webinar: "Innovations in Immune Checkpoint Inhibitor Delivery" with Dr. Petros Grivas and @bhatia-s-md.bsky.social of @fredhutch.bsky.social education.binayfoundation.org/Vitual-Optim...